Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Cash from Investing Activities (2023 - 2025)

Historic Cash from Investing Activities for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $36000.0.

  • Camp4 Therapeutics' Cash from Investing Activities changed N/A to $36000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$506000.0, marking a year-over-year decrease of 2019.0%. This contributed to the annual value of -$441000.0 for FY2024, which is 3495.58% up from last year.
  • According to the latest figures from Q3 2025, Camp4 Therapeutics' Cash from Investing Activities is $36000.0.
  • Over the past 5 years, Camp4 Therapeutics' Cash from Investing Activities peaked at $36000.0 during Q3 2025, and registered a low of -$279000.0 during Q1 2025.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$203000.0 (2023), whereas its average is -$154500.0.
  • In the last 5 years, Camp4 Therapeutics' Cash from Investing Activities plummeted by 823.05% in 2024 and then tumbled by 176000.0% in 2025.
  • Over the past 3 years, Camp4 Therapeutics' Cash from Investing Activities (Quarter) stood at -$243000.0 in 2023, then decreased by 8.23% to -$263000.0 in 2024, then surged by 113.69% to $36000.0 in 2025.
  • Its last three reported values are $36000.0 in Q3 2025, -$279000.0 for Q1 2025, and -$263000.0 during Q4 2024.